Population Pharmacokinetics of MYL-1402O, a Proposed Biosimilar to Bevacizumab and Reference Product (Avastin®) in Patients with Non-squamous Non-small Cell Lung Cancer Article Early Access

International Collaboration

cited authors

  • Owen, Joel S.; Rackley, Russell J.; Hummel, Matthew A.; Roepcke, Stefan; Huang, Hannah; Liu, Mark; Idris, Tazeen A.; Murugesan, Sundara Moorthi Nainar; Marwah, Ashwani; Loganathan, Subramanian; Ranganna, Gopinath; Barve, Abhijit; Waller, Cornelius F.; Socinski, Mark A.

authors

Publication Date

  • October 4, 2023

webpage

published in

category